Functional studies have yet to be undertaken to establish which brain region subserves the parasympathetic regulation of the cerebral circulation. Using 31 anesthetized rats with precluded cervical sympathetic trunks, we therefore attempted to perform chemical stimulation of the greater petrosal nerve (GPN) cell group, which is a subgroup of the superior salivatory nucleus and sends off axons largely to the parasympathetic pterygopalatine ganglion via the GPN component of the facial nerve. The cerebrocortical blood flow was monitored with a laser-Doppler flowmeter. Unilateral stimulation of the GPN cell group by microinjection of L-glutamate reduced the ipsilateral cerebrocortical vascular resistance, maximally by 16.4+4.1% (mean+SD, n=61). The response was not mediated by the classic muscarinic receptors of the cerebral vessel wall. However, phannacological blockade of the peripheral parasympathetic ganglia and acute and chronic bilateral removal of the parasympathetic postganglionic fibers originating in the pterygopalatine ganglion abolished the response. The present data thus provide fumctional evidence that the GPN cell group may constitute a parasympathetic cerebrovasodilator center. (Circulation Research 1993;72:470-475) KEY WORDs * superior salivatory nucleus * parasympathetic nerves * postganglionic fibers cerebral circulation A mong the well-known parasympathetic components coursing in the cranial nerves,1 that in the facial (seventh) nerve2 appears to be predominant, based on its dense distribution at the cerebral blood vessels.34 In conformity with the pioneering work of Cobb and Finesinger5 in 1932, the parasympathetic neuron chain is best categorized as a cerebrovasodilator.6-10 To date, however, no physiological study has examined the vital question of the central origin of the parasympathetic preganglionic neurons of the facial nerve that regulates the cerebral blood vessels.
A mong the well-known parasympathetic components coursing in the cranial nerves,1 that in the facial (seventh) nerve2 appears to be predominant, based on its dense distribution at the cerebral blood vessels.34 In conformity with the pioneering work of Cobb and Finesinger5 in 1932, the parasympathetic neuron chain is best categorized as a cerebrovasodilator.6-10 To date, however, no physiological study has examined the vital question of the central origin of the parasympathetic preganglionic neurons of the facial nerve that regulates the cerebral blood vessels.
In the present study, an attempt was therefore made to perform chemical stimulation of the greater petrosal nerve (GPN) cell group, which is a subgroup of the superior salivatory nucleus and sends off axons largely to the parasympathetic pterygopalatine ganglionll-'3via the GPN component of the facial nerve.13-16 We provide physiological evidence that the GPN cell group may constitute a parasympathetic cerebrovasodilator center.
Materials and Methods Thirty-one male Wistar rats weighing 250-330 g were anesthetized with 2.5% halothane during surgery. Details of the general surgical procedures have been described by us elsewhere'7 and will only be summarized here. The femoral artery and vein were catheterized for continuous monitoring of the arterial pressure and administration of drug solutions, respectively. The cervical sympathetic trunks were severed bilaterally. The trachea was intubated. The animals were then paralyzed (0.3 mg/kg i.v. d-tubocurarine, given at hourly intervals), artificially ventilated, and maintained in a homeothermic state at 37°C. The head was held in a stereotaxic frame.
Continuous monitoring of the cerebrocortical blood flow was achieved with a laser-Doppler flowmeter (Biomedical Science, Japan) based on a procedure described elsewhere18 with slight modifications. A burr hole of 4-5-mm diameter was made on the parietal bone with a dental drill. The exposed dural surface was covered with normal saline. The probe of the flowmeter, carried on an electrode manipulator, was positioned 0.2-0.5 mm above the surface. The relative values of the blood flow were expressed in millimeters of pen displacement on a recorder, with zero flow corresponding to 0 mm. The relative values of the cerebrovascular resistance were later calculated by dividing the arterial pressure by the cortical blood flow. We consider that the baseline cerebrocortical blood flow in the present study was approximately 60-70 ml/min per 100 g, based on our previous data obtained by the microsphere technique in 26 rats under similar conditions of anesthesia and experimental setting. 17 The dorsal surface of the medulla was visualized by occipital craniectomy and covered with warmed saline. The halothane was then replaced with a-chloralose (50 mg/kg i.p.) and urethane (250 mg/kg i.p.) as anesthetic agents. Supplemental urethane was given at hourly intervals at a dose of 250 mg/kg.
We had provided beforehand a double-or quadruplebarreled glass micropipette (Clark Electromedical Instruments, United Kingdom) pulled to a tip diameter of [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] ,um.'7 Each lumen of the micropipette was filled with physiological buffer solution17 (vehicle), a solution of monosodium L-glutamate (13, 40, or 80 mM, Sigma Chemical Co., St. Louis, Mo.), or a dye solution (2% Pontamine sky blue, Nakarai Chemicals, Japan; or 2% india ink, No. 12, Fueki, Japan). Each of these drugs had been dissolved in the physiological buffer solution. The micropipette was manipulated by a stereotaxic technique. A smaller (50 nl) or larger (100 nl) dose of the drug solution was microinjected at a rate of 200 nl/min into the medulla with an individual 25 -,l Hamilton syringe mounted in a microinfusion pump (model IM-1, Narishige, Japan).
The cerebrovasodilator site was then explored by selectively stimulating medullary neuronal cell bodies with the glutamate solution19 (40 mM, 50 nl). The tip of the micropipette was fixed in place within a site that yielded the greatest response. We next examined the reproducibility of the cerebrovasodilator response and/or the concentration-response relation.
Subsequently, we observed the effects of pharmacological blockade (20 rats) and acute surgical removal (eight rats) of the cerebrovascular parasympathetic nerves on the response. In the pharmacological study, we used the muscarinic receptor antagonist scopolamine hydrobromide (Nakarai) and the autonomic ganglionic blocker pentolinium tartrate (Sigma). After the pentolinium tartrate treatment, a normal arterial pressure was maintained by continuous intravenous infusion of the sympathomimetic drug phenylephrine (0.01%, Sigma). Figure 3 .
We observed excellent reproducibility of the cerebrovasodilator response to the submaximal dose of glutamate (see data in Figure 4 obtained in three pairs of the first and second experimental runs), thereby ensuring minimal variation across time and a lack of neurotoxic effects of the glutamate.22 Subsequent intravenous injection of a large dose of scopolamine hydrobromide did not modify the cerebrovasodilator response ( Figures 3 and 4) . On the other hand, the response was abolished after intravenous administration of pentolinium tartrate (Figures 3 and 4) . Neither drug significantly altered the baseline level of the cerebrovascular resistance (p>0.05 by paired t test).
We found that whereas sham denervation did not modify the cerebrovasodilator response, subsequent acute bilateral denervation of the parasympathetic postganglionic fibers originating in the pterygopalatine ganglion abolished the response (Figures 3 and 4) . The denervation did not alter the baseline level of the cerebrovascular resistance (p>0.05 by paired t test).
Despite these surgical manipulations, the cerebrovascular responsiveness to hypercapnia remained well preserved (Figure 3 ).
In the chronic denervation study, it was found that glutamate injection into or in the close vicinity of the GPN cell group did not significantly alter the cerebrovascular resistance (99.7±2.9% of the baseline value, n =12, p>0.05 by paired t test, three rats).
Discussion
Our experiments demonstrated that unilateral chemical stimulation of the GPN cell group in rats with precluded cervical sympathetic trunks reduced the cerebrovascular resistance with an ipsilateral predominance. The data were analogous with previously reported results obtained by electrical stimulation of peripheral segments of the parasympathetic component of the facial nerve.5 10 The magnitude of the response that we observed was, however, noticeably small when compared with that elicited by electrical stimulation of the parasympathetic preganglionic'0 and postganglionic9 fibers. The latter two studies, like ours, also used laserDoppler flowmetry with acute preparation of a burr hole. We consider that the discrepancy could be attributable to a difference in the efficacy of each stimulus, i.e., chemical stimulation of the central nervous system versus electrical stimulation of peripheral parasympathetic fiber bundle.
Furthermore, we found that the response was not mediated by the muscarinic receptors of the cerebral vessel wall. However, pharmacological blockade of the parasympathetic ganglia and acute and chronic surgical denervation of the parasympathetic postganglionic fibers originating in the pterygopalatine ganglion4,20 did abolish the response. Therefore, we suggest that the GPN cell group may constitute a parasympathetic cerebrovasodilator center. 
